About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1203 record(s)
Req # A-2019-0013
All data and emails received and/or prepared from March 1, 2019 until December 2, 2019 regarding vaping related illnesses.Organization: Canadian Institutes of Health Research
March 2024
Req # A-2021-0021
All reports, briefing notes, budgets, and emails/correspondence pertaining to the New Brunswick Cluster of Neurological Syndrome of Unknown Cause, produced between January 1, 2020, and Nov 18, 2021.Organization: Canadian Institutes of Health Research
March 2024
Req # A-2022-0008
All records about how CIHR has responded to reports that the Canadian Common CV (Curriculum Vitae) has obstacles that impede disabled individuals from equal participation, from January 1, 2018 to May 14, 2022.Organization: Canadian Institutes of Health Research
March 2024
Req # A-2016-000420
Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings…Organization: Health Canada
March 2024
Req # A-2019-001464
All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of…Organization: Health Canada
March 2024
Req # A-2019-001525
The Clinical Overview, Clinical Summary of Efficacy and Clinical Summary of Safety submitted to Health Canada as part of the Supplemental New Drug Submission (SNDS) (control number: 204690; decision date: 2018-03-29) in respect of TALTZ.Organization: Health Canada
March 2024
Req # A-2020-001374
For the period 2015 to April 19, 2021, and in relation to natural health product brand names containing the phrase “glucosamine sulfate” or “glucosamine sulphate”, with license holders named WN Pharmaceuticals Ltd, Natural Factors Nutritional…Organization: Health Canada
March 2024
Req # A-2021-001830
A summary of the costs incurred to develop, advertise, and run the COVID Alert App program mentioned in this news story: https://globalnews.ca/news/8478550/attempts-improve-covid-alert-stall-lack-of-interest-provinces/. Records from the start of the…Organization: Health Canada
March 2024
Req # A-2021-001944
An analysis of the hazards present at the site and quantify any potential risk of historical exposusres, Canada Training Centre in Kemptville Ontario by Bluemetric Environmental Inc. A copy of this report as well as all all communications between…Organization: Health Canada
March 2024
Req # A-2022-000619
Any document containing information on the oversight or monitoring conducted by Health Canada with respect to personal cannabis cultivation, and any statistics, data or information of any nature or kind compiled by Health Canada or in the possession…Organization: Health Canada
March 2024